vimarsana.com
Home
Live Updates
Dr Gong on the EMBARK Trial Investigating Enzalutamide in nmCSPC : vimarsana.com
Dr Gong on the EMBARK Trial Investigating Enzalutamide in nmCSPC : vimarsana.com
Dr Gong on the EMBARK Trial Investigating Enzalutamide in nmCSPC
Jun Gong, MD, discusses the significance of the phase 3 EMBARK study of enzalutamide in nonmetastatic castration-sensitive prostate cancer.
Related Keywords
Jun Gong ,
Urologic Oncology Program ,
Samuel Oschin Comprehensive Cancer Institute ,
Pancreatic Cancer Research Group ,
Gastrointestinal Disease Research Group ,
Colorectal Cancer ,
Cedars Sinai Cancer ,
Edars Sinai Cancer ,
Prostate Cancer ,
Onclive Tv ,
Embark ,
Enzalutamide ,
Mcspc ,